​

Danaher (DHR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DHR Stock Forecast

Danaher stock forecast is as follows: an average price target of $292.40 (represents a 27.94% upside from DHR’s last price of $228.55) and a rating consensus of 'Buy', based on 22 wall street analysts offering a 1-year stock forecast.

DHR Price Target

The average price target for Danaher (DHR) is $292.40 based on 1-year price targets from 22 Wall Street analysts in the past 3 months, with a price target range of $315.00 to $275.00. This represents a potential 27.94% upside from DHR's last price of $228.55.

DHR Analyst Ratings

Buy

According to 22 Wall Street analysts, Danaher's rating consensus is 'Buy'. The analyst rating breakdown for DHR stock is 0 'Strong Buy' (0.00%), 15 'Buy' (68.18%), 6 'Hold' (27.27%), 1 'Sell' (4.55%), and 0 'Strong Sell' (0.00%).

Danaher Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 31, 2024Doug SchenkelWolfe Research$285.00$242.3217.61%24.70%
Oct 23, 2024Paul KnightKeyBanc$310.00$257.6720.31%35.64%
Oct 23, 2024Catherine SchulteRobert W. Baird$277.00$261.286.02%21.20%
Oct 23, 2024Puneet SoudaLeerink Partners$275.00$261.285.25%20.32%
Oct 01, 2024Jacob JohnsonStifel Nicolaus$315.00$273.6315.12%37.83%
Apr 23, 2024Justin BowersDeutsche Bank$270.00$236.0814.37%18.14%
Apr 17, 2024Rajesh KumarHSBC$280.00$240.3416.50%22.51%
Sep 27, 2023Paul KnightLoop Capital Markets$300.00$247.4421.24%31.26%
Jan 05, 2023Credit Suisse$300.00$266.3712.63%31.26%
Dec 14, 2022Deutsche Bank$310.00$276.6812.04%35.64%
Nov 29, 2022Barclays$277.00$261.166.07%21.20%
Jul 31, 2022Elizabeth GarciaUBS$297.00$291.471.90%29.95%
Jun 01, 2022Deane DrayRBC Capital$310.00$261.8318.40%35.64%
May 06, 2022Catherine SchulteRobert W. Baird$319.00$248.1528.55%39.58%
Apr 29, 2022Timothy DaleyWells Fargo$265.00$257.502.91%15.95%
Apr 27, 2022Deane DrayRBC Capital$299.00$250.9819.13%30.82%
Feb 06, 2022Catherine SchulteRobert W. Baird$334.00$287.6316.12%46.14%
Jan 30, 2022Matthew SykesGoldman Sachs$360.00$281.1128.06%57.51%
Jan 16, 2022Brendan LueckeBernstein$365.00$293.3124.44%59.70%
Oct 22, 2021Daniel BrennanCowen & Co.$360.00$312.9015.05%57.51%
Oct 22, 2021Paul KnightKeyBanc$345.00$312.9010.26%50.95%
Sep 10, 2021Katie TryhaneCredit Suisse$370.00$329.2612.37%61.89%
Jul 23, 2021Derik De BruinBank of America Securities$340.00$290.6216.99%48.76%
Jul 16, 2021Robert WassermanBenchmark Co.$330.00$284.1616.13%44.39%
Jun 18, 2021Erin WrightMorgan Stanley$288.00$256.2012.41%26.01%
Jun 18, 2021Liza GarciaWolfe Research$325.00$256.2026.85%42.20%

The latest Danaher stock forecast, released on Oct 31, 2024 by Doug Schenkel from Wolfe Research, set a price target of $285.00, which represents a 17.61% increase from the stock price at the time of the forecast ($242.32), and a 24.70% increase from DHR last price ($228.55).

Danaher Price Target by Period

1M3M12M
# Anlaysts-57
Avg Price Target-$292.40$287.43
Last Closing Price$228.55$228.55$228.55
Upside/Downside-100.00%27.94%25.76%

In the current month, the average price target of Danaher stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Danaher's last price of $228.55. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2024Raymond JamesOutperformOutperformHold
Oct 23, 2024Wells FargoEqual-WeightEqual-WeightHold
Oct 23, 2024StephensUnderperformUnderperformHold
Oct 23, 2024Cowen & Co.BuyBuyHold
Oct 23, 2024KeyBancOverweightOverweightHold
Oct 23, 2024Leerink PartnersOutperformOutperformHold
Oct 23, 2024BarclaysEqual-WeightEqual-WeightHold
Oct 22, 2024Goldman SachsNeutralNeutralHold
Oct 22, 2024William BlairOutperformOutperformHold
Oct 01, 2024Evercore ISIOutperformOutperformHold
Sep 30, 2024StephensOverweightInitialise
Aug 27, 2024Wells FargoOverweightEqual-WeightInitialise
Jul 24, 2024Cowen & Co.BuyBuyHold
Jul 24, 2024BarclaysEqual-WeightEqual-WeightHold
Jul 23, 2024Goldman SachsNeutralNeutralHold
Apr 24, 2024Cowen & Co.BuyBuyHold
Apr 23, 2024Deutsche BankBuyBuyHold
Apr 16, 2024HSBCBuyUpgrade
Feb 01, 2024NeedhamOverweightOverweightHold
Jan 31, 2024Raymond JamesOutperformOutperformHold
Jan 31, 2024RBC CapitalOutperformOutperformHold
Oct 25, 2023CitigroupBuyBuyHold
Oct 25, 2023Raymond JamesOutperformOutperformHold
Oct 25, 2023RBC CapitalOutperformOutperformHold
Sep 27, 2023KeyBancOverweightOverweightHold
Sep 27, 2023Goldman SachsBuyBuyHold
Sep 27, 2023Deutsche BankBuyBuyHold
Sep 27, 2023CitigroupNeutralNeutralHold
Sep 27, 2023Morgan StanleyEqual-WeightUnderweightDowngrade
Apr 26, 2023Credit SuisseNeutralNeutralHold
Apr 18, 2023WedbushOutperformUpgrade
Apr 18, 2023BTIGNeutralDowngrade
Apr 18, 2023Wolfe ResearchOutperformUpgrade
Apr 18, 2023CitigroupBuyUpgrade
Apr 18, 2023Morgan StanleyEqual-WeightUpgrade
Apr 18, 2023Wells FargoOverweightUpgrade
Apr 04, 2023BarclaysOverweightOverweightHold
Jan 05, 2023Credit SuisseNeutralDowngrade
Dec 14, 2022Deutsche BankBuyInitialise
Nov 29, 2022BarclaysOverweightOverweightHold
Jul 31, 2022UBSBuyInitialise
Jun 01, 2022RBC CapitalOutperformSector PerformUpgrade
Jun 01, 2022RBC CapitalSector PerformOutperformUpgrade
Apr 27, 2022RBC CapitalSector PerformSector PerformHold
Apr 26, 2022William BlairOutperformOutperformHold
Apr 25, 2022Zacks Investment ResearchHoldDowngrade
Jan 30, 2022Goldman SachsBuyBuyHold
Jan 16, 2022BernsteinOutperformInitialise

Danaher's last stock rating was published by Raymond James on Oct 23, 2024. The company gave DHR a "Outperform" rating, the same as its previous rate.

Danaher Financial Forecast

Danaher Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$3.78B-$7.16B$7.17B$8.37B$7.66B$7.75B$7.69B$8.15B$7.23B$7.22B$6.86B$6.76B$5.88B$5.30B$4.34B$2.84B$5.04B
Avg Forecast$7.53B$6.48B$6.52B$6.44B$6.91B$6.08B$6.08B$6.04B$6.39B$5.59B$5.59B$5.62B$6.13B$6.60B$7.12B$7.04B$7.90B$7.16B$7.30B$7.55B$7.92B$7.00B$6.72B$6.29B$6.58B$5.51B$4.95B$4.32B$4.80B$5.02B
High Forecast$7.66B$6.58B$6.62B$6.54B$7.02B$6.18B$6.17B$6.15B$6.43B$5.59B$5.59B$5.62B$6.46B$7.12B$7.23B$7.16B$8.03B$7.16B$7.30B$7.55B$7.92B$7.00B$6.72B$6.29B$6.58B$5.51B$4.95B$4.32B$4.80B$5.02B
Low Forecast$7.40B$6.36B$6.40B$6.32B$6.78B$5.97B$5.96B$5.90B$6.37B$5.58B$5.59B$5.62B$6.02B$5.36B$6.98B$6.91B$7.75B$7.16B$7.30B$7.55B$7.92B$7.00B$6.72B$6.29B$6.58B$5.51B$4.95B$4.32B$4.80B$5.02B
# Analysts446437491364681812981488179111791317988
Surprise %------------0.62%-1.01%1.02%1.06%1.07%1.06%1.02%1.03%1.03%1.07%1.09%1.03%1.07%1.07%1.00%0.59%1.00%

Danaher's average Quarter revenue forecast for Mar 24 based on 6 analysts is $5.62B, with a low forecast of $5.62B, and a high forecast of $5.62B. DHR's average Quarter revenue forecast represents a 48.78% increase compared to the company's last Quarter revenue of $3.78B (Dec 23).

Danaher EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts446437491364681812981488179111791317988
EBITDA------------$1.34B-$1.46B$2.40B$2.26B$2.58B$2.77B$2.15B$2.73B$2.00B$2.72B$2.64B$2.12B$1.59B$1.78B$1.06B$1.67B$1.19B
Avg Forecast$2.28B$1.96B$1.98B$1.95B$2.09B$1.84B$1.84B$1.83B$1.94B$1.69B$1.69B$1.80B$1.86B$2.00B$2.16B$1.64B$2.40B$2.20B$2.25B$1.30B$2.57B$2.16B$2.07B$1.94B$2.03B$1.70B$1.52B$1.03B$1.48B$1.55B
High Forecast$2.32B$1.99B$2.01B$1.98B$2.13B$1.87B$1.87B$1.86B$1.95B$1.69B$1.69B$2.17B$1.96B$2.16B$2.19B$1.97B$2.88B$2.20B$2.25B$1.56B$3.08B$2.16B$2.07B$1.94B$2.03B$1.70B$1.52B$1.23B$1.48B$1.55B
Low Forecast$2.24B$1.93B$1.94B$1.92B$2.05B$1.81B$1.81B$1.79B$1.93B$1.69B$1.69B$1.44B$1.82B$1.62B$2.12B$1.31B$1.92B$2.20B$2.25B$1.04B$2.05B$2.16B$2.07B$1.94B$2.03B$1.70B$1.52B$820.19M$1.48B$1.55B
Surprise %------------0.72%-0.68%1.46%0.94%1.17%1.23%1.66%1.06%0.93%1.31%1.36%1.05%0.94%1.17%1.03%1.13%0.77%

6 analysts predict DHR's average Quarter EBITDA for Mar 24 to be $1.80B, with a high of $2.17B and a low of $1.44B. This is 34.98% upper than Danaher's previous annual EBITDA (Dec 23) of $1.34B.

Danaher Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts446437491364681812981488179111791317988
Net Income------------$1.08B-$1.11B$1.45B$2.23B$1.57B$1.68B$1.73B$1.79B$1.16B$1.78B$1.70B$1.24B$883.50M$927.30M$595.10M$1.28B$668.00M
Avg Forecast$2.05B$1.48B$1.52B$1.61B$1.78B$1.41B$1.41B$1.47B$1.56B$1.14B$1.15B$1.02B$1.40B$1.32B$1.30B$924.29M$1.57B$1.49B$1.55B$730.66M$1.68B$1.42B$1.35B$1.16B$1.24B$896.46M$719.99M$577.60M$821.70M$755.19M
High Forecast$2.10B$1.51B$1.56B$1.65B$1.82B$1.44B$1.44B$1.52B$1.59B$1.14B$1.15B$1.22B$1.46B$1.51B$1.33B$1.11B$1.89B$1.49B$1.55B$876.79M$2.02B$1.42B$1.35B$1.16B$1.24B$896.46M$719.99M$693.12M$821.70M$755.19M
Low Forecast$2.01B$1.45B$1.49B$1.57B$1.74B$1.37B$1.38B$1.42B$1.56B$1.14B$1.15B$813.37M$1.37B$1.15B$1.27B$739.43M$1.26B$1.49B$1.55B$584.53M$1.35B$1.42B$1.35B$1.16B$1.24B$896.46M$719.99M$462.08M$821.70M$755.19M
Surprise %------------0.77%-0.85%1.57%1.42%1.06%1.09%2.36%1.06%0.82%1.32%1.47%1.00%0.99%1.29%1.03%1.55%0.88%

Danaher's average Quarter net income forecast for Mar 24 is $1.02B, with a range of $813.37M to $1.22B. DHR's average Quarter net income forecast represents a -5.77% decrease compared to the company's last Quarter net income of $1.08B (Dec 23).

Danaher SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts446437491364681812981488179111791317988
SG&A------------$2.04B-$2.19B$2.15B$2.19B$2.15B$2.08B$2.09B$2.29B$2.06B$1.97B$1.88B$1.96B$1.80B$1.69B$1.46B$578.40M$1.65B
Avg Forecast$2.22B$1.91B$1.92B$1.90B$2.04B$1.79B$1.79B$1.78B$1.88B$1.65B$1.65B$2.49B$1.81B$1.94B$2.10B$2.26B$2.02B$2.11B$2.15B$1.79B$2.16B$2.06B$1.98B$1.85B$1.94B$1.62B$1.46B$1.42B$1.41B$1.48B
High Forecast$2.26B$1.94B$1.95B$1.93B$2.07B$1.82B$1.82B$1.81B$1.89B$1.65B$1.65B$2.99B$1.91B$2.10B$2.13B$2.72B$2.42B$2.11B$2.15B$2.15B$2.59B$2.06B$1.98B$1.85B$1.94B$1.62B$1.46B$1.70B$1.41B$1.48B
Low Forecast$2.18B$1.87B$1.89B$1.86B$2.00B$1.76B$1.76B$1.74B$1.88B$1.65B$1.65B$1.99B$1.78B$1.58B$2.06B$1.81B$1.61B$2.11B$2.15B$1.43B$1.73B$2.06B$1.98B$1.85B$1.94B$1.62B$1.46B$1.13B$1.41B$1.48B
Surprise %------------1.13%-1.05%0.95%1.09%1.02%0.97%1.17%1.06%1.00%0.99%1.01%1.01%1.11%1.16%1.03%0.41%1.12%

Danaher's average Quarter SG&A projection for Mar 24 is $2.49B, based on 6 Wall Street analysts, with a range of $1.99B to $2.99B. The forecast indicates a 22.43% rise compared to DHR last annual SG&A of $2.04B (Dec 23).

Danaher EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts446437491364681812981488179111791317988
EPS------------$1.45-$1.50$1.96$3.03$2.13$2.28$2.35$2.50$1.56$2.44$2.33$1.69$1.18$1.27$0.83$1.75$0.90
Avg Forecast$2.82$2.03$2.09$2.21$2.44$1.93$1.93$2.02$2.14$1.57$1.57$1.72$1.91$1.81$1.78$2.00$2.26$2.00$2.08$2.36$2.26$1.91$1.82$1.56$1.67$1.21$0.97$0.91$1.11$1.02
High Forecast$2.88$2.08$2.13$2.26$2.49$1.97$1.97$2.09$2.17$1.57$1.57$1.72$2.00$2.07$1.82$2.05$2.30$2.00$2.08$2.36$2.26$1.91$1.82$1.56$1.67$1.21$0.97$0.91$1.11$1.02
Low Forecast$2.75$1.98$2.04$2.16$2.38$1.88$1.89$1.95$2.13$1.57$1.57$1.72$1.87$1.58$1.74$1.96$2.20$2.00$2.08$2.36$2.26$1.91$1.82$1.56$1.67$1.21$0.97$0.91$1.11$1.02
Surprise %------------0.76%-0.84%0.98%1.34%1.06%1.10%0.99%1.11%0.82%1.34%1.49%1.02%0.98%1.31%0.92%1.58%0.88%

According to 6 Wall Street analysts, Danaher's projected average Quarter EPS for Mar 24 is $1.72, with a low estimate of $1.72 and a high estimate of $1.72. This represents a 18.39% increase compared to DHR previous annual EPS of $1.45 (Dec 23).

Danaher Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
DHRDanaher$233.53$292.4025.21%Buy
TMOThermo Fisher Scientific$528.84$640.8821.19%Buy
IDXXIDEXX Laboratories$427.09$510.0019.41%Buy
GHGuardant Health$34.84$40.6016.53%Buy
MTDMettler-Toledo$1.25K$1.41K13.28%Hold
RVTYRevvity$114.75$127.8611.42%Buy
CRLCharles River Laboratories$189.33$209.0010.39%Buy
AAgilent$136.46$147.408.02%Buy
ILMNIllumina$143.12$147.783.26%Buy
WATWaters$373.72$356.80-4.53%Buy

DHR Forecast FAQ

Is Danaher a good buy?

Yes, according to 22 Wall Street analysts, Danaher (DHR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 15 'Buy' recommendations, accounting for 68.18% of DHR's total ratings.

What is DHR's price target?

Danaher (DHR) average price target is $292.4 with a range of $275 to $315, implying a 27.94% from its last price of $228.55. The data is based on 22 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Danaher stock go up soon?

According to Wall Street analysts' prediction for DHR stock, the company can go up by 27.94% (from the last price of $228.55 to the average price target of $292.4), up by 37.83% based on the highest stock price target, and up by 20.32% based on the lowest stock price target.

Can Danaher stock reach $300?

DHR's highest twelve months analyst stock price target of $315 supports the claim that Danaher can reach $300 in the near future.

What are Danaher's analysts' financial forecasts?

Danaher's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $25.1B (high $25.52B, low $24.61B), average EBITDA is $7.6B (high $7.73B, low $7.46B), average net income is $6.07B (high $6.22B, low $5.91B), average SG&A $7.4B (high $7.52B, low $7.25B), and average EPS is $8.32 (high $8.52, low $8.1). DHR's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $26.97B (high $27.41B, low $26.47B), average EBITDA is $8.17B (high $8.31B, low $8.02B), average net income is $6.67B (high $6.82B, low $6.51B), average SG&A $7.95B (high $8.08B, low $7.8B), and average EPS is $9.15 (high $9.34, low $8.93).

Did the DHR's actual financial results beat the analysts' financial forecasts?

Based on Danaher's last annual report (Dec 2023), the company's revenue was $14.03B, which missed the average analysts forecast of $26.88B by -47.79%. Apple's EBITDA was $5.2B, missing the average prediction of $7.65B by -32.01%. The company's net income was $4.74B, missing the average estimation of $4.94B by -3.92%. Apple's SG&A was $7.33B, missing the average forecast of $8.11B by -9.66%. Lastly, the company's EPS was $6.38, missing the average prediction of $7.5 by -14.98%. In terms of the last quarterly report (Dec 2023), Danaher's revenue was $3.78B, missing the average analysts' forecast of $6.13B by -38.30%. The company's EBITDA was $1.34B, missing the average prediction of $1.86B by -27.96%. Danaher's net income was $1.08B, missing the average estimation of $1.4B by -22.68%. The company's SG&A was $2.04B, beating the average forecast of $1.81B by 12.70%. Lastly, the company's EPS was $1.45, missing the average prediction of $1.91 by -24.21%